Literature DB >> 3141108

Interaction of ciprofloxacin with ampicillin and vancomycin for Streptococcus faecalis.

S M Smith1, R H Eng.   

Abstract

Streptococcus faecalis is known to be resistant to killing by many of the commonly used antimicrobial agents. Ciprofloxacin, a member of the quinolone class of compounds, was studied for its ability to inhibit and to kill S. faecalis. The rate of killing by ciprofloxacin was slow and was comparable to that of ampicillin or vancomycin. The antimicrobial effect of combining ciprofloxacin with ampicillin or with vancomycin was also studied using checkerboard double-dilution and killing kinetics. There was no synergy or antagonism between ciprofloxacin and either cell wall active agent. Unlike the aminoglycosides, the addition of ciprofloxacin did not produce additional killing over that of ampicillin or of vancomycin alone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141108     DOI: 10.1016/0732-8893(88)90115-0

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  5 in total

Review 1.  Screening and treatment of infections caused by resistant enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 2.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

3.  Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.

Authors:  V Korten; J F Tomayko; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

4.  Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem?

Authors:  F L Sapico; H N Canawati; V J Ginunas; D S Gilmore; J Z Montgomerie; W J Tuddenham; R R Facklam
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

Review 5.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.